based on 5 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 5 analysts offering long term price targets for Glenmark Life Sciences Ltd. An average target of ₹1138.6
Source: S&P Global Market Intelligence
Glenmark Life Sciences Ltd price forecast by 5 analysts
Upside of8.45%
High
₹1295
Target
₹1138.60
Low
₹1015
Glenmark Life Sciences Ltd target price ₹1138.6, a slight upside of 8.45% compared to current price of ₹1036.35. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Glenmark Life Sciences Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Glenmark Life Sciences Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.49 % |
3 Month Return | -19.61 % |
1 Year Return | + 64.22 % |
Market Stats | |
Previous Close | ₹1,049.85 |
Open | ₹1,049.85 |
Volume | 80.15K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹12,864.11Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹12,864.11 Cr |
P/B Ratio | 4.07 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 21.07 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹12,864.11 Cr | 8.05% | 0.51 | NA | NA | |
NA | ₹226.88 Cr | 89% | 0.51 | NA | NA | |
NA | ₹352.64 Cr | 68.63% | 0.68 | ₹6 Cr | ₹305 Cr | |
NA | ₹658.33 Cr | 447.24% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹302.57 Cr | 463.22% | 0.53 | NA | NA |
Organisation | Glenmark Life Sciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Glenmark Life Sciences Ltd
Glenmark Life Sciences Reports Q2 FY25 Financial Decline - 24 Oct, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 10.76% to 12.98% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 4.82% to 7.85% in Sep 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 1.01% to 2.82% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 137.9% return, outperforming this stock by 67.7%
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 64.8% return, outperforming this stock by 0.6%
Promoter Holding Down
Promoters have decreased holdings from 82.85% to 75.00% in Sep 2024 quarter
Price Dip
In the last 3 months, GLS stock has moved down by -19.6%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 75% | ||
Foreign Institutions | 7.85% | 63.12 | |
Mutual Funds | 2.82% | 178.19 | |
Retail Investors | 12.98% | 20.63 | |
Others | 1.34% | 140.56 |
Glenmark Life Sciences Ltd’s net profit fell -19.72% since last year same period to ₹95.32Cr in the Q2 2024-2025. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -14.5% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2023, Glenmark Life Sciences Ltd has declared dividend of ₹22.50 - translating a dividend yield of 4.20%.
Read More about DividendsBearish
Neutral
Bullish
Glenmark Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Glenmark Life Sciences Ltd (GLS) share price today is ₹1036.35
Glenmark Life Sciences Ltd is listed on NSE
Glenmark Life Sciences Ltd is listed on BSE
Today’s traded volume of Glenmark Life Sciences Ltd(GLS) is 80.15K.
Today’s market capitalisation of Glenmark Life Sciences Ltd(GLS) is ₹12864.11Cr.
Glenmark Life Sciences Ltd(GLS | Price |
---|---|
52 Week High | ₹1335.1 |
52 Week Low | ₹627.15 |
Glenmark Life Sciences Ltd(GLS) share price is ₹1036.35. It is down -22.38% from its 52 Week High price of ₹1335.1
Glenmark Life Sciences Ltd(GLS) share price is ₹1036.35. It is up 65.25% from its 52 Week Low price of ₹627.15
Glenmark Life Sciences Ltd(GLS | Returns |
---|---|
1 Day Returns | -13.5% |
1 Month Returns | -4.49% |
3 Month Returns | -19.61% |
1 Year Returns | 64.22% |